Skip to main content
Log in

A New Model of Vaginal Infection by Candida albicans in Rats

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Vulvovaginal candidiasis (VVC) is regarded as an important public health issue, and several aspects of its pathogenesis are not yet sufficiently clear. Experimental in vivo models of vaginal infection with Candida albicans have been extremely useful in the identification of factors concerning hormonal influences on the infection, the virulence of the yeasts, the susceptibility, and the treatment of the infection. The development of easily manageable, reproducible, and economically viable animal models of VVC is highly important. We describe a simple experimental model of VVC in rats, using a pharmaceutical brand of estradiol hexa-hydrobenzoate for human treatment. All the steps of this model were standardized; and after the experiments, the rats were euthanized for further examination of their tissues by scanning and transmission electron microscopy. Standardized features included the use of non-ovariectomized rats, sterile distilled water as the hormone vehicle, estradiol hexa-hydrobenzoate administered at 0.20 mg/week/rat fractionated three times/week, and a yeast suspension of 5 × 108 yeasts/ml in a single vaginal administration 1 week after hormone induction. In this way, 100% of the rats were in pseudo-estrus and developed and maintained the infection until the third week of the experiment. Electron microscopy observation of the vagina of the rats confirmed the presence of both pseudo-estrus and vaginal infection. The standardized experimental model proved inexpensive, reproducible, and easily feasible for the induction of vaginal infection with C. albicans and may help to clarify important aspects of the pathogenesis and treatment of VVC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369:1961–71.

    Article  PubMed  Google Scholar 

  2. Sobel JD. Candidal vulvovaginitis. Clin Obstet Gynecol. 1993;36:153–212.

    Article  CAS  PubMed  Google Scholar 

  3. Mardh PA, Rodrigues AG, Genc M, Nivikova N, Martinez-de-Oliveira J, Guaschino S. Facts and myths on recurrent vulvovaginal candidosis: a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int J STD AIDS. 2002;13:522–39.

    Article  PubMed  Google Scholar 

  4. Souza PC, Storti-Filho A, Souza RJS, Damke E, Mello ICJ, Pereira MW, Svidizinski TIE, Lopes-Consolaro ME. Prevalence of Candida sp. in the cervical–vaginal cytology stained by Harris–Shorr. Arch Gynecol Obstet. 2009;279:625–9.

    Article  CAS  PubMed  Google Scholar 

  5. Patel DA, Gillespie B, Sobel JD, Leaman D, Nyirjesy P, Weitz MV, Foxman B. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study. Am J Obstet Gynecol. 2004;190:644–53.

    Article  PubMed  Google Scholar 

  6. Corsello S, Spinillo A, Osnengo G, Penna C, Guaschino S, Beltrame A, Blasi N, Festa A. An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol. 2003;110:66–72.

    Article  PubMed  Google Scholar 

  7. Sobel JD, Myers PG, Kayne D, Levison ME. Adherence of Candida albicans to human vaginal and buccal epithelial cells. J Infect Dis. 1981;143:76–82.

    CAS  PubMed  Google Scholar 

  8. Irie MMT, Consolaro MEL, Guedes TA, Donatti L, Patussi EV, Svidzinski TIE. A simplified technique for evaluating the adherence of yeasts to human vaginal epithelial cells. J Clin Lab Anal. 2006;20:195–203.

    Article  Google Scholar 

  9. Alvares CA, Svidzinski TIE, Consolaro MEL. Vulvovaginal candidíasis: susceptibility factors of the host and virulence of the yeasts. J Bras Patol Med Lab. 2007;43:319–27.

    Article  Google Scholar 

  10. Kalo-Klein A, Witkin SS. Candida albicans: cellular immune system interactions during different stages of the menstrual cycle. Am J Obstet Gynecol. 1989;161:1132–6.

    CAS  PubMed  Google Scholar 

  11. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci. 1988;544:547–57.

    Article  CAS  PubMed  Google Scholar 

  12. Kaushic C, Zhou F, Murdin AD, Wira CR. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect Immun. 2000;68:4207–16.

    Article  CAS  PubMed  Google Scholar 

  13. Cruz FCM, Soares-Júnior JM, Mosquette R, Simões MJ. Aspectos morfológicos da junção escamo-colunar de ratas em estro permanente e tratadas com associação de estrogênio e glicocorticóide. Rev Bras Ginecol Obstet. 2004;26:597–602.

    Article  Google Scholar 

  14. Mandl AM, Zuckerman S. Numbers of normal and atretic oocytes in unilaterally spayed rats. J Endocrinol. 1951;7:112–9.

    Article  CAS  PubMed  Google Scholar 

  15. Sobel JD, Muller G, McCormick JF. Experimental chronic vulvovaginal candidiasis. Sabour. 1985;23:199–206.

    CAS  Google Scholar 

  16. Fidel PL Jr, Lynch ME, Sobel JD. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect Immun. 1993;61:1990–5.

    CAS  PubMed  Google Scholar 

  17. Clemons KV, Spearow JL, Parmar R, Espiritu M, Stevens DA. Genetic susceptibility of mice to Candida albicans vaginitis correlates with host estrogen sensitivity. Infect Immun. 2004;72:4878–80.

    Article  CAS  PubMed  Google Scholar 

  18. Fidel PL Jr, Cutright J, Steele C. Effects of reproductive hormones on experimental vaginal candidiasis. Infect Immun. 2000;68:651–7.

    Article  CAS  PubMed  Google Scholar 

  19. National Committee for Clinical Laboratory Standards (NCCLS). Reference TEMhod. Wayne: NCCLS; 1998.

    Google Scholar 

  20. Kurtzman CP, Fell JW. The yeast. A taxonomic study. Amsterdam: Elsevier; 1998.

    Google Scholar 

  21. Sugita T, Kurosaka S, Yajite M, Sato H, Nishikawa A. Extracellular proteinase and phospholipase activity of three genotypic strains of a human pathogenic yeast, Candida albicans. Microbiol Immunol. 2002;46:881–3.

    CAS  PubMed  Google Scholar 

  22. De Bernardis F, Lucciarini R, Boccanera M, Amantini C, Arancia S, Morrone S, Mosca M, Cassone A, Santoni G. Phenotypic and functional characterization of vaginal dendritic cells in a rats model of Candida albicans vaginitis. Infect Immun. 2006;74:4282–94.

    Article  PubMed  Google Scholar 

  23. Wozniak KL, Wormley FL Jr, Fidel PL Jr. Candida-specific antibodies during experimental vaginal candidiasis in mice. Infect Immun. 2002;70:5790–9.

    Article  CAS  PubMed  Google Scholar 

  24. Yener T, Tunc AT, Aslan H, Aytan H, Caliskan AC. Determination of oestrous cycle of the rats by direct examination: how reliable? Anat Histol Embryol. 2007;36:75–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Márcia E. L. Consolaro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carrara, M.A., Donatti, L., Damke, E. et al. A New Model of Vaginal Infection by Candida albicans in Rats. Mycopathologia 170, 331–338 (2010). https://doi.org/10.1007/s11046-010-9326-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-010-9326-1

Keywords

Navigation